According to a June 23 report from the financial analysts at Herald KS, USANA Health Sciences (NYSE:USNA) has a current $2.79 billion valuation.
The company has risen 75.25% since June 23, 2017 and is uptrending. It has outperformed the S&P 500 by 62.68%. The company reported 2017 revenue at $1.05 billion.